Wesana

EXCLUSIVE: Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway.

[Video] Daniel Carcillo On Psychedelics For TBI, Wesana Partnering With MAPS & Mike Tyson Collaboration

This article by Sarah Abelsohn was originally published on Psychedelic Spotlight and appears here with permission.